Back
Understanding and Treating Systemic Sclerosis (SSc): SYSMIC and Beyond

You are invited to the upcoming Research Grand Rounds 2026 on “Understanding and Treating Systemic Sclerosis (SSc): SYSMIC and Beyond”.
About the Event
Fibrotic diseases can cause significant organ dysfunction and affect nearly a billion people worldwide. Among them, SSc remains one of the most challenging autoimmune diseases given its marked clinical heterogeneity. Patients can differ substantially in organ involvement, disease progression, and response to treatment.
Join Assoc Prof Behmoaras and Assoc Prof Low as they explore the role of monocyte and macrophage-related pathways in fibrosis and SSc, drawing insights from the Singapore Systemic Sclerosis Precision Medicine (SYSMIC) project. They will also discuss how advances in molecular profiling ,multi-omics, imaging and targeted therapeutics are deepening our understanding of disease mechanisms and enabling more precise, individualised approaches to treatment and disease monitoring.
About the Speakers
Assoc Prof Jacques Behmoaras is the Associate Professor in the Centre for Biomedical Data Science at Duke-NUS Medical School and Co-director, Quantitative Biology and Medicine PhD Programme. His research focuses on understanding and targeting macrophage biology in complex inflammatory disorders and during immune ageing. Assoc Prof Behmoaras' group revealed the primary role of macrophage gene and metabolic networks in inflammatory and fibrotic diseases. His current projects combine multi-omics approaches and AI-based methodology for identifying clinically actionable pathways in immune dysfunction. He is also the Duke-NUS lead for SYSMIC.
Assoc Prof Andrea Low is a Senior Consultant in Rheumatology and Immunology at Singapore General Hospital (SGH) and a Clinical Associate Professor of the SingHealth Duke-NUS Academic Clinical Programme. Her clinical and research interest lies in SSc. She is a clinician-scientist who spearheaded a nationwide collaborative SSc research workgroup and established the Systemic Sclerosis Cohort in Singapore (SCORE) and the Asia-Pacific Incident SSc Cohort, a network spanning 16 centres. Assoc Prof Low is also a recipient of the National Medical Research Council Clinician Scientist Award and Lead PI of IAF-PP-funded SYSMIC, a precision medicine project in SSc focused on dissecting and stratifying the disease for targeted therapies.
About the Facilitator
Dr Maria Noviani is a Consultant in Rheumatology and Immunology at SGH. Her research focuses on SSc, with a particular interest in understanding the immune and tissue mechanisms driving disease activity and progression, with the aim of translating mechanistic insights into clinically relevant therapeutic strategies. She is currently pursuing the clinician-scientist track and embarking on a PhD in Clinical and Translational Sciences at Duke-NUS Medical School under the NMRC Research Training Fellowship.
Registration Details
Sign up here now or scan the QR code in the poster below.
Date and Time
18 Nov 2026 @ 12:30 - 18 Nov 2026 @ 13:30
Registration
https://synapxe.zoom.us/webinar/register/WN_lCHZqG9DSXia3I_8YI_NsA#/